Over the past 10 years, Nycomed has compiled an impressive track record in research in Canada. As of June 2008, the company has been involved with more than 50 clinical trials, enrolling almost 10,000 patients. At present, three clinical studies at various stages are ongoing, involving more than 240 physicians and including over 1,300 patients across Canada.

Nycomed actively supports the objective of discovering new medicines that improve the quality of health care for every Canadian.